Your browser doesn't support javascript.
loading
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
Cognetti, David M; Johnson, Jennifer M; Curry, Joseph M; Kochuparambil, Samith T; McDonald, Darren; Mott, Frank; Fidler, Mary J; Stenson, Kerstin; Vasan, Nilesh R; Razaq, Mohammad A; Campana, John; Ha, Patrick; Mann, Grace; Ishida, Kosuke; Garcia-Guzman, Miguel; Biel, Merrill; Gillenwater, Ann M.
Afiliação
  • Cognetti DM; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Johnson JM; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Curry JM; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Kochuparambil ST; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • McDonald D; Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Mott F; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Fidler MJ; Department of Medical Oncology, Virginia Piper Cancer Institute, Minneapolis, Minnesota, USA.
  • Stenson K; Department of Otolaryngology-Head and Neck Surgery, Virginia Piper Cancer Institute, Minneapolis, Minnesota, USA.
  • Vasan NR; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Razaq MA; Department of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, Illinois, USA.
  • Campana J; Department of Otorhinolaryngology, Rush University Medical Center, Chicago, Illinois, USA.
  • Ha P; Department of Otolaryngology-Head and Neck Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Mann G; Division of Hematology and Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
  • Ishida K; Department of Otolaryngology, University of Colorado Head and Neck Specialists, Denver, Colorado, USA.
  • Garcia-Guzman M; Division of Head and Neck Surgical Oncology, University of California San Francisco, San Francisco, California, USA.
  • Biel M; Department of Clinical Development, Rakuten Medical, Inc, San Mateo, California, USA.
  • Gillenwater AM; Department of Biostatistics, Rakuten Medical Japan, Tokyo, Japan.
Head Neck ; 43(12): 3875-3887, 2021 12.
Article em En | MEDLINE | ID: mdl-34626024
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Imunoterapia / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Head Neck Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço / Imunoterapia / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Head Neck Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos